ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia

ClinicalTrials.gov ID: NCT00004107

Public ClinicalTrials.gov record NCT00004107. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 4:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase I/II Radioimmunotherapy of Non-Hodgkin's Lymphoma With High-Dose 90Y-Labeled Humanized LL2 Anti-CD-22 Antibody and Peripheral Blood Stem Cell Rescue

Study identification

NCT ID
NCT00004107
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Other
Enrollment
18 participants

Conditions and interventions

Interventions

  • autologous bone marrow transplantation Procedure
  • filgrastim Biological
  • indium In 111 monoclonal antibody MN-14 Radiation
  • peripheral blood stem cell transplantation Procedure
  • yttrium Y 90 epratuzumab Radiation

Procedure · Biological · Radiation

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 1998
Primary completion
Apr 30, 2001
Completion
Not listed
Last update posted
Jun 21, 2011

Started 1998

United States locations

U.S. sites
4
U.S. states
2
U.S. cities
4
Facility City State ZIP Site status
Garden State Cancer Center Belleville New Jersey 07103
St. Barnabas Medical Center Livingston New Jersey 07039
St. Joseph's Hospital and Medical Center Paterson New Jersey 07503
University of Pennsylvania Cancer Center Philadelphia Pennsylvania 19104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00004107, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 21, 2011 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00004107 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →